Nutritional Status in Neuroblastoma in Sao Paolo, Brazil
NCT ID: NCT03517280
Last Updated: 2024-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2018-07-15
2023-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Nutritional Status of Childhood Neurological Tumors and Quality of Life
NCT07264023
Risk Model for Metastasis Detection of Neuroblastoma
NCT06703944
A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients
NCT01770626
Neuroblastoma Biology Study
NCT01587300
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with Neuroblastoma
Children undergoing treatment for Neuroblastoma at ITACI in Sao Paolo in Brazil who are under the age of 18 years.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age under 18 years
* Informed consent from a legal guardian to participate in the study
Exclusion Criteria
* First assessment performed more than 48 hours after the beginning of treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Tratamento do Câncer Infantil
OTHER
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Ladas, Phd, RD
Role: STUDY_DIRECTOR
Columbia University
Karina Viani, RD
Role: PRINCIPAL_INVESTIGATOR
Instituto de Tratamento do Câncer Infantil, Sao Paolo
Vicente Odone, MD, PhD
Role: STUDY_CHAIR
Instituto de Tratamento do Câncer Infantil, Sao Paolo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto de Tratamento do Câncer Infantil
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAR7865
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.